MedPath

Wound Antiseptic Study With Hypochlorous Acid & Iodopovidone

Phase 2
Conditions
Surgical Site Infection
Interventions
Registration Number
NCT00692757
Lead Sponsor
Universidad TecnolĂłgica de Pereira
Brief Summary

The purpose of this study is to determine whether hypochlorous acid is an effective antiseptic agent to prevent surgical site infection.

Detailed Description

A topical antimicrobial that decrease the bacterial bioburden of surgical wounds without impairing the wound's ability to heal is a need. A stabilized form of hypochlorous acid has been demonstrated in vitro and in animal studies to possess properties that could fulfill these criteria but it is imperative to assess its efficacy and safety in humans.

To assess hypochlorous acid efficacy and safety, it was designed a clinical controlled randomized trial to compare hypochlorous acid to iodopovidone, the gold standard, in preoperative scrub of surgical area.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
432
Inclusion Criteria
  • All patients over 18 years old, who are going to be operated
  • Classification of surgical wounds according to the National Research Council as class I or II
  • Risk index classification of the American Society of Anaesthesiology (ASA) as ASA 1 or 2
Exclusion Criteria
  • Patients requiring mesh or prosthesis or orthesis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BIodopovidoneIodopovidone
AHypochlorous acidHypochlorous acid
Primary Outcome Measures
NameTimeMethod
Surgical site infection ratesuntil one month (weekly)
Secondary Outcome Measures
NameTimeMethod
Decreasing Colony Forming Unit count (CFU/mL) after using the skin topic antiseptic in surgical siteone week

Trial Locations

Locations (1)

Hospital Universitario San Jorge (HUSJ)

🇨🇴

Pereira, Risaralda, Colombia

© Copyright 2025. All Rights Reserved by MedPath